KLOW
Research Grade
$159
$159.00
1 × $159.00 pick 2 and save $15.90
Buy More Save More
Same day dispatch · free express shipping over $250
Certificates of Analysis
All certificates →Current batch · on shelf
99.31%
Purity by HPLC · identity confirmed by MS
17 August 2026
- Batch
- APL-KLOW80-2608-03
- Net content
- 80.58 mg
- Specification
- ≥98.0% combined purity · passes
Every batch is analysed in-house by HPLC and mass spectrometry and ships with a batch-specific Certificate of Analysis. Independent third-party verification is added to select batches; none is published for KLOW yet.
Molecular Details
Every batch is analysed in-house by HPLC & mass spectrometry and ships with a Certificate of Analysis; select batches are additionally verified by an independent third-party laboratory.
Usage & Storage
Description
Four-peptide research blend (GHK-Cu, BPC-157, TB-500, KPV) studied in tissue-repair, angiogenesis, and inflammatory-signalling models.
- Four-peptide blend: GHK-Cu, BPC-157, TB-500, KPV
- Studied in tissue-repair and ECM-remodelling models
- Investigated in angiogenesis and cell-migration research
- KPV studied in NF-kB and inflammatory-cytokine signalling
- Research Grade purity >=98%
KLOW is a four-peptide research blend combining GHK-Cu, BPC-157, TB-500, and KPV in a single lyophilised vial. Each component acts on a distinct pathway. GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is studied for copper-dependent enzyme activity, extracellular-matrix remodelling, and broad gene-expression modulation. BPC-157, a pentadecapeptide derived from the human gastric protein BPC, has been characterised in angiogenesis, nitric-oxide, and cytoprotection models. TB-500 is the synthetic full-length form of thymosin beta-4, which regulates actin sequestration and cell migration. KPV, the C-terminal tripeptide of alpha-melanocyte-stimulating hormone, has been investigated for NF-kB modulation and inflammatory-cytokine signalling. The blend is studied as a multi-pathway tool in tissue-repair and inflammation research models. Supplied strictly for in-vitro laboratory research. Not for human or veterinary consumption.
Frequently Asked Questions
Is KLOW legal to buy in Australia?
KLOW is supplied strictly as a research chemical for in-vitro laboratory use. It is not approved for human therapeutic use in Australia and is not for human or animal consumption. Researchers are responsible for compliance with Therapeutic Goods Administration (TGA) regulations and their institution's protocols.
What purity is KLOW?
We specify ≥98% purity — the High-Tier Research Grade (commercial RUO) standard. Every batch is analysed in-house by HPLC and mass spectrometry and ships with a Certificate of Analysis; select batches also undergo independent, third-party purity verification.
Does KLOW ship with a Certificate of Analysis (COA)?
Yes — every batch ships with a batch-specific COA documenting HPLC purity and mass-spectrometry identity. 3 KLOW batch certificates are published in full at australianpeptidelabs.com.au/certificates/klow, so the analysis can be read before ordering and the batch number printed on the vial matched against it.
Where can I buy KLOW in Australia?
KLOW can be ordered here from Australian Peptide Labs for in-vitro research use, dispatched same day from within Australia with a COA included.
Do you provide dosing or administration guidance for KLOW?
No. As these compounds are supplied for laboratory research only, we do not provide dosing or administration protocols. Our research library covers reconstitution and concentration calculations for in-vitro work.